WTW jumps as BMO upgrades to Outperform after post-earnings plunge
Willis Towers Watson shares rose about 3% Friday, May 1, 2026, as investors reacted to a fresh analyst upgrade following a steep post-earnings selloff earlier this week. BMO Capital raised its rating to Outperform and set a $300 price target, helping fuel a rebound from the April 29–30 slide tied to softer revenue trends in Q1 results.
1. What’s moving the stock
Willis Towers Watson (WTW) is moving higher on May 1, 2026, after an analyst upgrade helped shift sentiment following a sharp, earnings-driven drawdown earlier this week. BMO Capital Markets upgraded WTW to Outperform from Market Perform and set a $300 price target, framing the setup as more attractive after the late-April selloff.
2. The backdrop: earnings shock and fast rebound
The upgrade lands immediately after WTW’s first-quarter 2026 earnings release on April 30, 2026, which sparked a steep decline as investors focused on revenue/growth concerns even as profitability metrics held up better. Market commentary around the quarter highlighted margin expansion alongside softer-than-expected revenue growth, which triggered the abrupt reset in the shares before today’s bounce.
3. Key numbers investors are watching next
Beyond the rating change, investors are weighing whether the post-earnings reset has already discounted near-term growth pressure and whether WTW can stabilize organic growth through 2026. From the quarter’s read-through, attention is also on capital return commitments—WTW reiterated a share-repurchase target of at least $1 billion for the year and reported Q1 organic growth of about 3% with adjusted operating margin around 22.3%—figures that may support the idea of a valuation floor after the selloff.
4. What could keep volatility elevated
With the stock still digesting an earnings-driven repricing, incremental changes in analyst models, price targets, and forward growth expectations can drive outsized moves from day to day. Any follow-on updates about booking trends in Risk & Broking, performance in Health, Wealth & Career, or cadence of buybacks could quickly tilt the debate toward “temporary slowdown” versus “structural growth deceleration.”